跳至主要内容
临床试验/NCT05406882
NCT05406882招募中2 期

The Effects of Bifidobacterium and Lactobacillus Tablets Combined With Compound Glutamine in the Prevention and Treatment of Radiation Proctitis.

West China Hospital2 个研究点 分布在 1 个国家目标入组 176 人开始时间: 2022年4月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
176
试验地点
2
主要终点
Incidence of radiation proctitis

研究概览

简要总结

Radiation proctitis is a common complication after radiation therapy for pelvic tumors. The investigators found that live bifidobacterium and lactobacillus tablets combined with compound glutamine enteric-coated capsules can significantly relieve the symptoms of radiation proctitis through preliminary clinical practice, but the mechanism is unknown. Through a prospective randomized controlled study, this study intends to investigate the incidence of grade 2 or higher acute radiation proctitis in patients of locally advanced rectal cancer after radiotherapy with the combined therapy. And through various scales, next-generation sequencing methods and other methods to evaluate the clinical symptoms, colonoscopy, imaging, and changes in the species and abundance of intestinal flora before and after treatment. To further explore the related pathways and mechanisms affecting radiation proctitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • locally advanced rectal adenocarcinoma diagnosed by histopathology; clinical stage T3/4 or N+(AJCC,8th), no metastasis; and planned to receive preoperative neoadjuvant concurrent chemoradiotherapy.
  • without other malignant tumors;
  • Those without serious heart, liver, kidney and other diseases;
  • ECOG score: 0-1.

排除标准

  • Complicated with ulcerative colitis or Crohn's disease;
  • Complicated with severe organ insufficiency, severe diabetes, and heart disease;
  • Pregnant and lactating women;
  • Abnormal bowel movements with systemic and metabolic diseases;
  • The patient has a history of using systemic antibiotics and intestinal active bacteria in the past 1 month.

研究组 & 干预措施

combination therapy group

Experimental

From the first day of chemoradiotherapy, live combined Bifidobacterium and Lactobacillus tablets(2000mg each time, 3 times/day) combined with compound glutamine enteric-coated capsules (3 capsules each time, 3 times/day) until 1 month after the end of chemoradiotherapy.

干预措施: Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules (Drug)

结局指标

主要结局

Incidence of radiation proctitis

时间窗: two months

Incidence of grade ≥2 radiation proctitis in combination therapy group

次要结局

  • remission rate of radiation proctitis(two months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wang Xin

Professor

West China Hospital

研究点 (2)

Loading locations...

相似试验